Top in hem/onc: Vitamin D deficiency and breast cancer risk; the perpetual ‘yes’
Click Here to Manage Email Alerts
A recent study found that individuals from underrepresented populations with vitamin D deficiency may be at a higher risk for breast cancer.
The findings reveal a potential path for intervention in this patient population, according to researchers. It was the top story in hematology/oncology last week.
The second top story was a blog post by Elizabeth Rubin, MD, emergency medicine attending physician at Cedars-Sinai Medical Center, about the personal and professional trap of always saying “yes,” and the importance of giving yourself permission to set boundaries.
Read these and more top stories in hematology/oncology below:
Black, Hispanic women with vitamin D deficiency may be at higher risk for breast cancer
Black/African American and Hispanic/Latina women who have low vitamin D concentrations may be more likely to be diagnosed with breast cancer than those with adequate concentrations, according to a study published in Cancer. Read more.
BLOG: The perpetual ‘yes’
My whole life has been about compliance. People pleasing. Pleasing parents, teachers, supervisors. Residency directors. Medical directors. Admissions counselors. Compliance officers. Nursing managers. Supervisors. In order to get to where I am today, I became the perpetual professional “yes man.” Read more.
Patients with lung cancer show ‘incredible toughness’ during COVID-19 pandemic
Patients with non-small cell lung cancer exhibited less depression and anxiety when receiving treatment during the COVID-19 pandemic than healthy individuals, according to a study in Journal of National Comprehensive Cancer Network. Read more.
Aromatase inhibitors reduce breast cancer recurrence vs. tamoxifen for certain women
Use of an aromatase inhibitor instead of tamoxifen reduced the risk for breast cancer recurrence among premenopausal women with ER-positive disease who received ovarian suppression, according to a study published in The Lancet Oncology. Read more.
COVID-19 prevention must extend beyond vaccines for patients receiving cell therapies
Infection mitigation with vaccines is essential for patients with hematologic malignancies because they are at increased risk for severe infection, hospitalization and mortality if they contract COVID-19. Read more.